首页> 外国专利> PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM

PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM

机译:神经保护作用的药物组合物,以液化剂型形式以六亚甲基二胺-双(N-单核糖基-L-谷氨酰胺-L-赖氨酸)为基础进行肠胃外应用

摘要

FIELD: medicine; pharmacy.SUBSTANCE: invention relates to medicine and pharmacy and relates to a pharmaceutical composition of neuroprotective action in the form of a lyophilisate for the manufacture of injection or infusion dosage forms containing as an active ingredient hexamethylenediamine bis-(N-monosuccinyl-L-glutamyl-L-lysine) and lyoprotectants and cryoprotectants in a certain quantitative ratio of the components used as functional additives, when using the recommended modes of drying and freezing.EFFECT: implementation of the invention allows to create a stable dosage form, optimal for storage and use, and also to receive the preparation providing increase in duration of a finding of a dipeptide in a system blood-groove in comparison with its substance.5 cl, 4 tbl, 11 ex
机译:领域:医学;发明领域本发明涉及药物和药学,并且涉及冻干物形式的神经保护作用的药物组合物,用于制备注射剂或输注剂型,所述剂型包含作为活性成分的六亚甲基二胺双-(N-单琥珀酰基-L-谷氨酰胺基) -L-赖氨酸),冻干保护剂和冷冻保护剂,当使用推荐的干燥和冷冻方式时,以一定定量比例用作功能添加剂的成分。效果:本发明的实施允许创建稳定的剂型,最适合于储存和冷冻。的用途,并且还接受与该物质相比在系统血槽中发现二肽持续时间更长的制剂。5cl,4 tbl,11 ex

著录项

  • 公开/公告号RU2017118538A3

    专利类型

  • 公开/公告日2018-12-03

    原文格式PDF

  • 申请/专利权人

    申请/专利号RU20170118538

  • 发明设计人

    申请日0000-00-00

  • 分类号A61K9/19;A61K38/05;A61K47/10;A61P25/28;

  • 国家 RU

  • 入库时间 2022-08-21 11:47:09

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号